Epigenetic modifications confer stable transcriptional patterns in the brain, and both normal and abnormal brain function involve specialized brain regions. We examined DNA methylation by whole-genome bisulfite sequencing in neuronal and nonneuronal populations from four brain regions (anterior cingulate gyrus, hippocampus, prefrontal cortex, and nucleus accumbens) as well as chromatin accessibility in the latter two. We find pronounced differences in both CpG and non-CpG methylation (CG-DMRs and CH-DMRs) only in neuronal cells across brain regions. Neuronal CH-DMRs were highly associated with differential gene expression, whereas CG-DMRs were consistent with chromatin accessibility and enriched for regulatory regions. These CG-DMRs comprise ~12 Mb of the genome that is highly enriched for genomic regions associated with heritability of neuropsychiatric traits including addictive behavior, schizophrenia, and neuroticism, thus suggesting a mechanistic link between pathology and differential neuron-specific epigenetic regulation in distinct brain regions. NATuRe NeuRosCIeNCe | VOL 22 | FEBRUARY 2019 | 307-316 | www.nature.com/natureneuroscience 307
D istinct cognitive functions and behaviors are often correlated with particular regions and/or cell types in the brain; most disease-based brain research is focused on identifying the anatomical structures that mediate normal function, for example, the hippocampus in memory, the prefrontal cortex in cognition, and the nucleus accumbens in addictive behavior. Further, many neuropsychiatric diseases preferentially affect individual neuronal subpopulations present in particular brain regions. The epigenome is particularly important in maintaining cellular identity and responding to environmental perturbations; 1 therefore, mapping the cell type-and brain region-specific transcriptional and epigenetic landscapes is necessary for identifying functional genomic differences that contribute to disease phenotypes. Recent transcriptome analyses have revealed extensive differences between non-cerebellar human brain regions 2 and between distinct neuronal 3 and glial 4 subpopulations in mice. Substantial transcriptional heterogeneity also exists among single cells profiled in mammalian cortical regions [5] [6] [7] . Single-cell DNA methylation 8 within a single brain region has only recently been measured, and the specific locations and functional consequences of methylation changes among cell types remain underexplored.
In contrast to gene expression, few, if any, DNA methylation differences among phenotypically normal non-cerebellar human brain regions have been reported [9] [10] [11] . DNA methylation is known to be altered in patients with neuropsychiatric disease, including schizophrenia 12 , Alzheimer's disease 13 , and major depressive disorder 14 . The only whole-genome bisulfite sequencing (WGBS) analyses across multiple human brain regions 9, 15 found few differences among cortical tissues. The apparent lack of epigenetic diversity among brain regions is surprising, given the known transcriptional diversity. Importantly, large-scale -omics 12, 16 and case-control 17 studies are predominately conducted using bulk tissues comprised of neuronal and non-neuronal cell populations at variable proportions. Although the authors of these studies acknowledge the confounding potential due to cellular heterogeneity, a robust reference of sorted populations from multiple brain regions would greatly improve current computational deconvolution strategies.
In contrast to studies in mice 3, 18, 19 , few studies have examined DNA methylation between cellular subpopulations isolated from human brain tissue 20 . Neurons are easily distinguished from nonneurons (astrocytes, oligodendrocytes, microglia, and epithelial cells) using the nuclear neuronal marker NeuN. DNA methylation differences between these two broadly defined populations have been widely reported 21, 22 and have been assessed genome-wide within a single brain region across development 22 and in the context of several neurodegenerative diseases 23 . Still, a comprehensive analysis of brain region-specific DNA methylation has not been performed using sorted nuclei isolated from human tissues.
Here, we addressed this knowledge gap by analyzing the DNA methylation landscape (both CpG and non-CpG) using WGBS in fractionated neuronal and non-neuronal nuclei (n = 45) and bulk tissues (n = 27) isolated from four post-mortem brain regions: dorsolateral prefrontal cortex (BA9), anterior cingulate gyrus (BA24), hippocampus (HC), and nucleus accumbens (NAcc). We also examined both gene expression (n = 20) and chromatin accessibility (n = 22) in NAcc and BA9 nuclei. Importantly, we find that regions of differential methylation, specifically within the neuronal population, are highly enriched for heritability of schizophrenia, addictive behavior, and neuroticism. extended our previously published statistical method 26 to accommodate multigroup comparisons while accounting for the variation between biological replicates. This new method allows us to simultaneously compare all 45 samples and identify regions of differential methylation between any two groups. mCG. We found substantial (> 10%) mean methylation differences among all four brain regions in the NeuN + population (Fig. 1b) in addition to the previously reported 21, 22 'cell type' differences between neuronal and non-neuronal nuclei ( Supplementary  Fig. 4a ). We identified 97,924 autosomal cell type CG-DMRs, of which 21,802 are novel 21, 22, 27 , and 19,072 large blocks of differential mCG (family-wise error rates (FWER) ≤ 5%) with neurons being primarily hypermethylated, consistent with their global hypermethylated status 21, 22 ( Supplementary Fig. 1e , Supplementary  Tables 4-7) . These cell type CG-DMRs clearly distinguish NeuN + from NeuN − nuclei and are present at the promoters of many cell type-specific genes ( Supplementary Fig. 4a,b) .
Given the large methylation differences among NeuN + nuclei, we repeated our differential methylation analysis on the NeuN + and NeuN − samples separately and compared the results to those generated from bulk tissues. We identified 13,074 autosomal neuronal (NeuN + ) CG-DMRs between brain regions containing > 1% of all CpGs analyzed (FWER < 5%) ( Fig. 1b) . These neuronal CG-DMRs, as for the cell type CG-DMRs, were enriched in regulatory regions that have been (1) defined by H3K27ac in human brain regions 28 , (2) identified as permissive enhancers across many cell types and tissues 29 , and (3) identified using a map of chromatin states in four brain regions 15 and in regions of open chromatin (Fig. 1c ). In contrast, we found few autosomal CG-DMRs among NeuN − nuclei (114 CG-DMRs) or bulk tissues (71 CG-DMRs) from these brain regions (Supplementary Tables 4, [8] [9] . These findings demonstrate that methylation differences among neurons from distinct brain regions are masked by the substantial variation in cellular heterogeneity across samples.
Several patterns emerged upon hierarchical clustering of methylation levels over neuronal CG-DMRs, similar to those seen in cancer-to-normal comparisons 30 (Fig. 1d ). The largest clusters (groups 1 and 2) consisted of symmetric methylation differences enriched for regulatory regions (Fig. 1e ). The other group consisted primarily of CG-DMRs representing shifts in methylation boundaries and was enriched in promoters, CpG islands (CGIs), and shores. These CG-DMRs (group 3) represent the smallest fraction of our neuronal CG-DMRs, but their enrichment is similar to CG-DMRs we previously identified as a consequence of oncogenic transformation of B cells using the Epstein-Barr virus 31 . These data suggest that methylation is altered in specific ways depending on the genomic feature, with focal increases or decreases in methylation at regulatory regions and more subtle spreading or shrinking of methylation boundaries at promoter-associated features.
Recent single-cell analyses have clearly shown that epigenetic and transcriptional profiles reflect distinct neuronal subpopulations with distinct functions 5, 8 . Therefore, it is unsurprising that the neuronal compositions of the brain regions we analyzed are reflected in their DNA methylation profiles ( Supplementary Fig. 2b ). Unlike NAcc (composed primarily of inhibitory GABAergic medium spiny neurons (MSNs)), HC, BA9, and BA24 are heterogeneous, containing both excitatory and inhibitory subpopulations 5, 8 . The majority of neuronal CG-DMRs (11, 895) distinguish the NAcc from the other brain regions. Using the Genomic Regions Enrichment of Annotations Tool (GREAT) 32 , we found that regions of hypomethylation in NAcc were enriched in categories highly relevant to MSN function: dopamine receptor signaling pathway (q value = 2.59 × 10 −24 ), adenylate cyclase-activating dopamine receptor signaling pathway (q value = 3.55 × 10 −18 ), and synaptic transmission, dopaminergic (q value = 5.21 × 10 −5 ) ( Supplementary Table 10 ).
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Examples of hypomethylated genes include those encoding markers of GABAergic neurons (BCL11B and DARPP-32) ( Fig. 1f ) and dopamine receptors (DRD1 and DRD3) ( Supplementary Fig. 4c ).
In contrast, regions of hypermethylation were enriched in multiple brain development categories (q values < 1 × 10 −11 ) ( Supplementary  Table 10 ). 
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Given the overwhelming differences between the NAcc and the other brain regions, we hypothesized that neuronal CG-DMRs among BA9, BA24, and HC could be obscured. Therefore, we repeated our analysis using only the neuronal samples from these regions, resulting in the identification of 208 autosomal neuronal CG-DMRs including 25 CG-DMRs unique to this analysis (Supplementary Fig. 4d and Supplementary Tables 4 and 11) . Again, we find clusters of CG-DMRs representing boundary shifts and focal changes, such as that shown in the promoter of SATB2 ( Supplementary Fig. 4c ).
Previous studies have identified large blocks of differential methylation during brain development and cancer-normal comparisons 16, 30 . We also identify 1,808 blocks of differential mCG among neurons from our four brain regions; the majority (964) of which have a mean methylation difference ≥ 10% ( Supplementary Tables 4  and 12 ). Interestingly, 23% of these blocks cover the entirety of a protein-coding gene, including BCL11B ( Fig. 1f ) and GABRB2 ( Supplementary Fig. 4f and Supplementary Table 12 ).
mCH. In addition to mCG, neurons and embryonic stem cells also have extensive non-CpG methylation (mCH). While mCH and mCG are spatially correlated 33, 34 , there is evidence to suggest that they can have independent functions in the brain 19, 22 . In agreement with previous reports, we detected the highest methylation levels (~10%) in the CA context of our NeuN + samples ( Supplementary  Fig. 1f ). mCH clearly distinguished NAcc from the other tissues by PCA, similar to mCG ( Fig. 2a ). Additionally, we observed segregation of CA and CT contexts but high concordance of signal between strands, and a linear relationship between methylation levels in the two contexts ( Supplementary Fig. 5 ). This finding suggests a single underlying signal in mCH that is reflected in both contexts and strands.
We further extended our previously published statistical method used to identify CG-DMRs 26 to map differential mCH. Using this method, which for the first time accounts for biological variability between samples, we identified a large number of CH-DMRs (covering a total of 40 Mb) ( Supplementary Table 13 ). We visualized the similarities between mCH in different contexts and strands by generating a mC z score for each CH-DMR ( Fig. 2b shows CA-DMRs on the forward strand, Supplementary Fig. 6 for other strands and contexts). This analysis indicates that strand and context are paired within an individual for NAcc samples, with some separation in the other brain regions, presumably due to the larger overall similarity of methylation. Finally, we observe that 93% of CT-DMRs overlap CA-DMRs. Given these findings, we merged contexts and strands and termed these CH-DMRs for the analyses described below.
CH-DMRs are highly enriched in neuronal CG-DMRs (with 15% overlapping a neuronal CG-DMR or block), and the two marks are highly concordant in these regions ( Supplementary  Fig. 6d ). However, CH-DMRs are more enriched over differentially expressed genes (DEGs) (identified between NeuN + samples from NAcc and BA9, and discussed in a later section) and their promoters compared to neuronal CG-DMRs ( Fig. 2c ). RGS9, which encodes a member of the regulator of G-protein signaling family, is shown as an example gene that is highly upregulated in NAcc neurons (60-fold) and has CH-DMRs covering the majority of the gene body along with multiple CG-DMRs ( Fig. 2d ).
Differential chromatin accessibility and methylation intersect at brain region-specific neuronal regulatory regions. We measured gene expression (via RNA-seq) and chromatin accessibility (via ATAC-seq 35 ) in neuronal and non-neuronal populations between BA9 and NAcc from six additional donors (Supplementary Table 1 ). We identified 2,952 DEGs between these neuronal populations and only one between non-neuronal nuclei (FDR < 5%) ( Fig. 3a,b ; Supplementary Tables 14-16 ). Genes expressed at a higher level in NAcc (n = 1,473) were enriched in gene ontology categories of particular relevance to MSN function: regulation of catecholamine secretion (q value = 8.6 × 10 −4 ), striatum development (q value = 1.8 × 10 −3 ), and opioid signaling pathway (q value = 5.4 × 10 −5 ) ( Supplementary Table 17 ). In contrast, genes expressed at a higher level in BA9 (n = 1,479) were enriched in categories related to more general neuronal functions: neuron development (q value = 9.53 × 10 −30 ), small GTPase mediated signal transduction (q value = 1.57 × 10 −11 ), and axon guidance pathway (q value = 4.12 × 10 −13 ).
Chromatin accessibility distinguished cell types and brain regions via PCA (Fig. 3c) ; although, in contrast to DNA methylation, clustering of samples based on correlation distance across all open chromatin regions (OCRs) did not distinguish brain regions within the neuronal cell type (compare Supplementary Fig. 2e with Supplementary Fig. 7a ). Similar to previous reports 36 , 163,026 of the 283,812 OCRs tested were differentially accessible (FDR < 5%) between NeuN + and NeuN − nuclei, termed cell type differentially accessible regions (DARs) ( Supplementary Fig. 7b and Supplementary Table 18 ). We further identified 68,021 'neuronal' DARs (only 13 identified among non-neuronal nuclei) between NAcc and BA9 (FDR < 5%) ( Fig. 3d ,e and Supplementary Tables 19-21). OCRs were enriched over multiple features, including gene-centric features such as promoters and exons, and depleted in intergenic and 'open sea' regions ( Fig. 3f ). In contrast, neuronal DARs lacked strong enrichment for any specific genomic feature, with the exception of neuronal CG-DMRs.
Given this enrichment of neuronal CG-DMRs in DARs, we further investigated the overlap between these features using the 12,895 CG-DMRs identified between NAcc and BA9 neurons. Only 10% of DARs overlapped CG-DMRs, and conversely, 55% of CG-DMRs overlapped DARs. This was true even when restricted to the most divergent DARs (absolute fold change > 2, 12% overlap CG-DMRs). The direction of change in DARs and CG-DMRs is highly concordant with 99.9% of neuronal CG-DMRs having higher methylation when the region is less accessible, consistent with earlier reports in mice 3 . Further, we observed consistent methylation differences near all DARs ( Fig. 3g ) and some degree of change in accessibility surrounding CG-DMRs ( Fig. 3h ). Together, these data suggest that these distinct epigenetic modalities are weakly dependent, and that which of these modalities exhibit the strongest change can vary, probably due to genome location. Differential mCH is more strongly correlated with differential gene expression than either mCG or chromatin accessibility. We next investigated the relationship between differential expression of protein-coding genes, differential methylation, and differential accessibility. An inverse relationship between global genic cytosine methylation and gene expression in neurons is well-established ( Supplementary Fig. 8a ), and this relationship is maintained when correlating differential methylation and differential expression between NAcc and BA9 ( Supplementary Fig. 8b ). Likewise, differential accessibility and expression are positively correlated ( Supplementary Fig. 8c ). CG-DMRs that overlap DARs revealed a stronger correlation with gene expression than CG-DMRs alone, which was not the case with CA-DMRs ( Supplementary Fig. 8d,e ).
Both DARs and DMRs preferentially occur within DEGs, with CG-DMRs and DARs near the TSS and CA-DMRs and CG-blocks distributed across the gene body ( Fig. 4a ). Additionally, CA-DMRs have the strongest correlation with expression over gene bodies, followed by CG-blocks ( Fig. 4b) . Interestingly, as a larger portion of the gene body is covered by a CA-DMR, that gene is more likely to be differentially expressed ( Fig. 4c ). This is not the case for DARs, CG-DMRs, or CG-blocks. We also find that protein coding genes with CA-DMRs tend to have a lower average expression across all neuronal samples (0.58 versus 1.83 reads per kilobase of transcript, ResouRce Nature NeuroscieNce per million mapped reads (RPKM), respectively; P value < 2.2 × 10 −16 ; Mann-Whitney) even when differentially expressed (0.78 versus 2.03 RPKM, respectively; P value < 2.2 × 10 −16 ; Mann-Whitney). This finding is consistent with a previous report 19 , and our own data, showing that lowly expressed genes have higher levels of mCA than highly expressed genes ( Supplementary Fig. 8f ). Together, these data support and extend previous assertions that among accessibility, mCG and mCH, mCH is the best predictor of gene expression 3 and further, that differential mCH specifically occurs over the gene bodies of DEGs, consistent with the recent finding that mCA serves to fine-tune gene expression of lowly expressed genes 19 .
Differential epigenomics identify transcription factors driving tissue-specific gene expression. We hypothesized that neuronal DARs and CG-DMRs could identify transcription factor (TF) binding motifs actively involved in regulating brain region-specific neuronal function. Using Haystack 37 , we find that these regions were enriched in immediate-early genes (IEGs), a class of TFs influenced by synaptic activity with important roles in regulating neuronal function 38 ( Fig. 4d and Supplementary Table 22 ). Several of these IEGs have been implicated in schizophrenia 39 and bipolar disorder 40 or play known roles in addiction 41 . DNA methylation influences binding of a diverse set of TFs 42 , many of which were enriched in regions of differential methylation and accessibility ( Fig. 4d ). Additionally, many TFs whose motifs were enriched were also differentially expressed between NAcc and BA9 neurons ( Fig. 4d ). When we restrict our analysis to those neuronal DARs and CG-DMRs that overlap promoters, we again detect enrichment for IEGs, specifically those encoding AP-1 family members (JUN, FOS, JDP2) ( Fig. 4e ). with all strands and contexts depicted in addition to CG-DMRs (mCG(S); obtained from small smoothing window) and blocks (mCG(L); obtained from large smoothing window). Average methylation values calculated from NeuN + nuclei isolated from BA24, BA9, HC, and NAcc. Regions of differential methylation are shaded in pink.
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Using our neuronal DARs, we employed a method that uses the accessibility of known TF binding sites in gene promoters and enhancers to calculate the importance of each TF for the observed gene expression profile 43, 44 . A positive regression coefficient indicates that the presence of a binding site for a particular TF predicts the target gene to be upregulated in NAcc versus BA9, and vice versa ( Fig. 4f; and Supplementary Table 23 ). MECP2, in particular, has a negative correlation coefficient ( Fig. 4f ) and is recruited to gene bodies by mCA to restrain transcription of lowly expressed genes 19 . Several TFs identified are known regulators of neuronal function (NFIX, MECP2, ARX, DLX1, ZBTB33/KAISO), whereas others have not been previously implicated in adult neuronal regulation (TEAD2, ARID5A/B, ZNF354C/hKID3) ( Fig. 4f ). Eight of these TFs were also differentially expressed between NAcc and BA9 ( Fig. 4 ). Taken together, our data show that differential methylation and accessibility mark regions of the genome that ResouRce Nature NeuroscieNce are regulated by synaptic activity-responsive TFs and suggest that these TFs regulate different targets in neurons from distinct brain regions.
Differential epigenomics identify regions of genetic importance for psychiatric disorders and behavioral-cognitive traits. The regions we identified using differential epigenomics, particularly INSM1  CREB3L2  BACH1::MAFK  PAX2  ARNTL  ZNF740  XBP1  TFE3  BHLHE40  RFX3  MEIS1  EGR2  TAL1::TCF3  EGR3 ResouRce Nature NeuroscieNce the CG-DMRs and DARs, have characteristics typical of regulatory elements, as expected 21, 22, 36 . Multiple studies have provided evidence that disease-associated genetic variation is enriched in regulatory elements active in physiologically relevant cell types 45, 46 . We therefore asked whether our differential epigenetic features were linked with neurological, psychiatric, and behavioral-cognitive phenotypes (brain-linked traits). We used stratified linkage disequilibrium score regression (SLDSR 45 ) to identify genomic features strongly associated with brain-linked traits. SLDSR partitions the heritability of a trait across a set of overlapping genomic features using summary statistics from a genome-wide association study (GWAS). We considered eight brain-derived genomic features: five 'differential' features identified in our analyses described above and three previously published 'non-differential' features (Methods). For each feature-trait combination, SLDSR reports a 'z score' , indicating whether the feature explains heritability beyond that explained by other features in the model, and an 'enrichment score' relating the heritability explained by the feature relative to that expected for a feature containing an equal number of SNPs. At least one of the eight brain-derived features explained a significant proportion of heritability for 13 of 27 brain-linked traits, whereas none explained a significant proportion of heritability for any negative control trait ( Fig. 5b , Supplementary  Fig. 9 , Supplementary Tables 24 and 25 ). The neuronal CG-DMRs have much higher enrichment scores than any of the non-differential features (Fig. 5a ), explaining additional heritability in six out of 13 traits, including schizophrenia and neuroticism, although their size (20-40× smaller) results in more uncertain estimates ( Supplementary Fig. 9b ).
We then performed a more stringent analysis of the five differential features by testing them against a baseline model that included the three non-differential brain-specific features. We found that when using this stringent approach, only CG-DMRs still contributed significantly (with a 14-fold enrichment) to the explained heritability of a brain-linked trait (schizophrenia; z-score adjusted P value = 0.013; Fig. 5c,d ; Supplementary Fig. 10a,b) .
Finally, we removed regions found by our differential approach from the non-differential features and repeated the analysis. This ensured that the heritability associated with a region common to two sets of brain-specific features is exclusively assigned to the differential feature. This approach highlights the trade-offs of using the highly specific differential features compared with the more general maps of brain regulatory regions, as evidenced by the much larger size of the non-differential features. On the basis of this analysis, the neuronal CG-DMRs are significantly associated with the heritability of schizophrenia, ADHD, BMI, IQ, and neuroticism ( Fig. 5f and Supplementary Fig. 11a) , with a 10-to 16-fold enrichment ( Fig. 5e and Supplementary Fig. 11b ).
Together, these data support the hypothesis that the genetic signal associated with neuropsychiatric traits is mediated through epigenetically distinct regions among neurons from diverse brain regions, particularly CG-DMRs. These analyses further demonstrate the power of using differential methods to precisely identify key regulatory regions, while also highlighting that, Results from running SLDSR using 30 GWAS traits with five brain-specific differential features, three brain-specific non-differential features (Brain H3K27ac 44 , CNS 51 , chromHMM 26 ), and 53 baseline features. Traits are stratified by whether they are viewed as brain related and by whether any of the brain-specific features explained additional heritability of the trait above the 53 baseline features (see Methods and Supplementary Table 24 ). Feature-trait combinations with a z score significantly larger than 0 (one-sided z test with alpha = 0.05, P values corrected within each trait using Holm's method) are shown by filled-in circles. a,b, Enrichment score (a) and coefficient z score (b) from running SLDSR for each of the eight brain-specific features separately combined with the 53 baseline features. c,d, Enrichment score (c) and coefficient z score (d) from running SLDSR for each of the five brain-specific differential features separately combined with baseline features. Baseline features for this analysis included the three brain-specific non-differential features. e,f, Enrichment score (e) and coefficient z score (f) from running SLDSR for each of the five brain-specific differential features separately combined with the baseline features. For this analysis, the baseline features included only the unique portions of the three brain-specific nondifferential features (non-differential feature regions that are also present in the differential features were excluded from the baseline).
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Discussion
This work represents the most comprehensive data set to date of WGBS across neuronal and non-neuronal populations and bulk tissues from multiple human brain regions. We have identified 12 Mb of differential mCG and 40 Mb of differential mCH among neuronal nuclei isolated from four brain regions implicated in neuropsychiatric disorders. We have further correlated these methylation changes to changes in both chromatin accessibility (118 Mb of differential accessibility) and gene expression (2,952 DEGs) in two of the tissues examined (NAcc and BA9). These data are made available as the 'BrainEpigenomeHub' UCSC track hub (see Data Availability) that can be used as a resource of normal epigenetic states and variation in the human brain to advance neuroepigenetics. Our findings have four main implications important for the field of neuroepigenetics. First, differential methylation among brain regions appears to be driven by the neuronal cell population. While the non-neuronal fraction can be divided into distinct subpopulations, we show through our analysis of sample-to-sample variability that this heterogeneity cannot account for the remarkable consistency of non-neuronal methylation across the human brain. Importantly, we have demonstrated that the ratio of neuronal to non-neuronal nuclei is highly variable, both among brain regions and between samples taken from a single brain region, even within a single individual. While the need to account for cellular heterogeneity is widely appreciated, these results should be of immense value in improving and benchmarking current computational deconvolution strategies applied to studies of human brain tissues.
Second, this study illustrates the power and specificity of differential epigenetics across brain regions, particularly the ability of differential mCG to identify regulatory elements and the ability of differential mCH to identify differential transcription. Whereas differential chromatin accessibility alone showed little enrichment in any particular genome feature, the specificity for regulatory elements (particularly for regions marked by brain-specific H3K27ac) increased nearly fivefold when combined with differential mCG.
Third, we find that regions of differential mCG and chromatin accessibility in neurons are enriched in binding sites for transcription factors regulated by synaptic activity (for example, FOS, JUN, MEF2C) (reviewed in 47 ), several possessing methylation sensitivity 42 . These data are consistent with a link between synaptic activity and epigenetic modification of transcription factor binding sites. Additionally, some transcription factors we identified play known roles in neurodevelopment, but have not previously been implicated in adult neuronal function (for example, HMGA1). These findings further illustrate the importance of differential epigenetic analysis in understanding normal neuronal function and provide novel targets for further investigation.
Finally, we show that tissue-specific differential mCG in the neuronal population has a fivefold greater enrichment for the heritability of neuropsychiatric diseases than the more generally defined regulatory genomic fraction identified in the human brain by ChromHMM and is contained within only 12 Mb of the human genome. While the majority of neuronal CG-DMRs (9,033/13,074; 69%) are found within genes, they primarily occur in intronic regions (7,669; 58.6%) that frequently harbor regulatory elements. Importantly, many of these differentially methylated genes have been repeatedly implicated in schizophrenia and other neuropsychiatric disorders. For example, we identified differential methylation in 19 of 36 schizophrenia GWAS-derived genes analyzed in a previous expression study 48 (CACNA1C, CACNB2, CACNA1I, GPM6A, GRAMD1B, SATB2, MEF2C, GRIN2A, MAD1L1, BCL11B, TCF4, TLE1, TLE3, PODXL, ZNF536, KCNV1, MMP16, MAN2A1, and GALNT10). Further, CG-DMRs are present in 56 ( Supplementary   Table 26 ) of the 237 genes recently shown to have differentially expressed features in prefrontal cortex schizophrenia versus control samples 49 . Clearly, these 12 Mb of regional differential methylation constitute critical sequences for future epigenetic analyses of neuropsychiatric diseases. It will be interesting to determine whether a subset of these regions are particularly associated with individual disorders and whether these associations are brain region-specific. These observations are consistent with the idea 50 that tissue-specific epigenetic patterning is frequently disrupted in human disease.
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Methods Experimental Methods. Human postmortem brain samples. Fluorescence-activated nuclear sorting (FANS) was performed on flash-frozen postmortem dorsolateral prefrontal cortex (BA9), hippocampus (HC), nucleus accumbens (NAcc), and anterior cingulate gyrus (BA24) from six individuals not affected with neurological or psychiatric disease. These samples underwent nuclei extraction and sorting as described below for subsequent DNA methylation analysis. Additionally, neuronal nuclei were isolated from the NAcc and BA9 of six individuals for RNA-seq and ATAC-seq analysis. To underscore the importance of cell sorting, we also prepared DNA from bulk tissue from the four brain regions (BA9, n = 9; HC, n = 7; NAcc, n = 7; BA24, n = 5). The majority of individuals were matched between sorted and bulk tissues, but not all. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications 20, 24 . All samples were obtained from the University of Maryland Brain and Tissue Bank, which is a Brain and Tissue Repository of the NIH NeuroBioBank (Supplementary Table 1 ). We have complied with all relevant ethical regulations. The research described here was classified as not human subjects research (NHSR) by the Johns Hopkins Institutional Review Board (IRB00061004). Data collection and analyses were not performed blind to tissue of origin and randomization was performed at the library preparation stage.
Nuclei extraction, FANS, and DNA isolation. Total nuclei were extracted via sucrose gradient centrifugation as previously described 29 Supplementary Fig. 1) . A small portion of the NeuN + and NeuN − nuclei were rerun on the sorter to validate the purity, which was greater than 95%. Immunonegative (NeuN − ) and immunopositive (NeuN + ) nuclei were collected in parallel. For DNA extraction, sorted nuclei were pelleted by adding 2 mL of sucrose solution, 50 uL of 1 M CaCl 2 , and 30 uL of Mg acetate to 10 mL of nuclei in PBS. This solution was incubated on ice for 15 min, then centrifuged at 3,000 r.p.m. for 20 min. The nuclear pellets were flash frozen in liquid nitrogen and stored at − 80 °C. DNA was extracted from the frozen nuclear pellets using the MasterPure DNA Extraction kit (cat# MC85200, Epicentre, Madison, Wisconsin, USA) following the manufacturer's instructions. For ATAC-seq and RNA-seq, nuclei were processed as described below.
Whole-genome bisulfite sequencing (WGBS). WGBS single indexed libraries were generated using NEBNext Ultra DNA library Prep kit for Illumina (cat# E7370L, New England BioLabs, Ipswich, MA, USA) according to the manufacturer's instructions with modifications. 400 ng gDNA was quantified by Qubit dsDNA BR assay (cat# Q32853, Invitrogen, Carlsbad, CA, USA), and 1% unmethylated lambda DNA (cat#: D1521, Promega, Madison, WI, USA) was spiked in to measure bisulfite conversion efficiency. Samples were fragmented to an average insert size of 350 bp using a Covaris S2 sonicator. Size selection was performed using AMPure XP beads, and insert sizes of 300-400 bp were isolated (0.4x and 0.2x ratios). Samples were bisulfite converted after size selection using the EZ DNA Methylation-Gold Kit (cat#: D5005, Zymo, Irvine, CA, USA) following the manufacturer's instructions. Amplification was performed after the bisulfite conversion using Kapa Hifi Uracil + (cat#: KK282, Kapa Biosystems, Boston, USA) polymerase using the following cycling conditions: 98 °C 45 Assay for transposase-accessible chromatin using sequencing. NeuN + and NeuN − nuclei were isolated as previously described, and 100,000 nuclei were used for ATAC-seq library preparation, as per standard protocols 38 . Briefly, 2× lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) was added to sorted nuclei to reach a final concentration of 1× and incubated 20 min on ice, then centrifuged for 10 min, as previously described. The transposition reaction was incubated for 1 h at 37 °C (Nextera DNA library prep kit; cat #:FC-121-1031, Illumina). After PCR amplification of libraries and column clean-up via the Qiagen MinElute PCR purification kit (cat#:28004, Qiagen, Valencia, CA, USA), an additional clean up with AMPure XP beads (0.8× ratio) was performed twice with 80% ethanol washes before quantification using a DNA High Sensitivity chip on a 2100 BioAnalyzer (Agilent, Santa Clara, CA, USA). Libraries were sequenced with the Illumina HiSeq4000 using 70 bp paired-end single indexed run with a 5% PhiX spike-in.
RNA sequencing. RNA isolated from bulk tissue was assessed, and only tissues with an RNA integrity number (RIN) ≥ 4 were used for nuclei isolation. NeuN + and NeuN − nuclei were isolated as previously described, with the addition of 20 U/mL RNase inhibitors (cat#: N8080119, Applied Biosystems) to the lysis buffer, sucrose solution, and antibody solution, and protease inhibitor cocktail (cat#: 50-751-7359, Amresco) was added to the lysis buffer only. Approximately 200,000 nuclei were sorted directly into RLT buffer + 150 mM 2-mercaptoethanol, and RNA was isolated using the Qiagen RNeasy Kit (cat #:74106, Qiagen, Valencia, CA, USA). Nuclear RNA quality was assessed by running samples on a Total RNA Pico Chip on a 2100 BioAnalyzer (Agilent, Santa Clara, CA, USA). RNA-seq libraries were created using 2.5 ng input RNA with the SMARTer ® Stranded Total RNA-Seq Kit -Pico Input Mammalian (cat#: 635005, Takara Bio, Mountain View, CA, USA) following the manufacturer's instructions for degraded RNA samples. Libraries were sequenced with the Illumina HiSeq4000 using 70 bp paired-end single indexed run with 5% PhiX spike-in.
Computational Methods. Annotation. The hg19 build of the human reference genome was used for all analyses. Only analyses of autosomal data are reported. Genes, exons, introns, and UTRs were taken from GENCODE v19 (https://www. gencodegenes.org/human/release_19.html) 51 . Gene bodies were defined by taking the union over all transcripts (transcription start site to transcription end site) for each gene. Promoters were defined as 4 kb centered on the transcription start site.
CpG islands data were downloaded from UCSC (http://genome.ucsc.edu/) 52, 53 . A GRanges object was created defining CpG shores as 2 kb flanking CpG islands and CpG shelves as 2 kb flanking CpG island shores. 'Open sea regions' are parts of the genome that are not CpG islands, shores or shelves.
The 15-state ChromHMM model for seven adult brain tissues (E071, E074, E068, E069, E072, E067, E073) from the Roadmap Epigenomics Project 15 was downloaded using the R/Bioconductor AnnotationHub package (v2.6.4).
Mapping and quality control of whole genome bisulfite sequencing (WGBS) reads.
We trimmed reads of their adaptor sequences using Trim Galore! (v0.4.0) (http:// www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and quality-trimmed using the following parameters: "trim_galore -q 25-paired ${READ1} ${READ2}". We then aligned these trimmed reads to the hg19 build of the human genome (including autosomes, sex chromosomes, mitochondrial sequence, and lambda phage (accession NC_001416.1) but excluding non-chromosomal sequences) using Bismark 54 (v0.14.3) with the following alignment parameters: "bismark-bowtie2 -X 1000-1 ${READ1} − 2 ${READ2}". Supplementary Tables 2 and 3 summarize the alignment results. Using the reads aligned to the lambda phage genome, we estimated that all libraries had a bisulfite conversion rate > 99%.
We then used bismark_methylation_extractor to summarize the number of reads supporting a methylated cytosine and the number of reads supporting an unmethylated cytosine for every cytosine in the reference genome. Specifically, we first computed and visually inspected the M-bias 28 of our libraries. Based on these results, we decided to ignore the first 5 bp of read1 and the first 10 bp of read2 in the subsequent call to bismark_methylation_extractor with parameters: "-ignore 5-ignore_r2 10". The final cytosine report file summarizes the methylation evidence at each cytosine in the reference genome.
Smoothing WGBS. We used BSmooth to estimate CpG methylation levels as previously described 28 . Specifically, we ran a 'small' smooth to identify small DMRs (smoothing over windows of at least 1 kb containing at least 20 CpGs) and a 'large' smooth to identify large-scale blocks (smoothing over windows of at least 20 kb containing at least 500 CpGs). Following smoothing, we analyzed all CpGs that had a sequencing coverage of at least 1 in all samples (n = 45 for sorted data, n = 27 for bulk data).
We also adapted BSmooth to estimate CpA and CpT methylation levels in NeuN + samples. Unlike CpGs, CpAs and CpTs are not palindromic, so were analyzed separately for each strand, for a total of 4 strand/dinucleotide combinations:
• mCA (forward strand) • mCA (reverse strand) • mCT (forward strand) • mCT (reverse strand) For each dinucleotide/strand combination we ran a single 'small-ish' smooth to identify DMRs (smoothing over windows of at least 3 kb containing at least 200 CpAs or CpTs). Following smoothing, we analyzed all CpAs and CpTs regardless of sequencing coverage.
Identification of small DMRs and large-scale blocks. We ran separate analyses to identify 6 types of differentially methylated regions:
ResouRce Nature NeuroscieNce 1. CG-DMRs: Using data from the 'small' smooth of CpG methylation levels 2. CG-blocks: Using data from the 'large' smooth of CpG methylation levels 3. CA-DMRs (forward strand): Using data from the 'small-ish' smooth of CpA methylation levels on the forward strand 4. CA-DMRs (reverse strand): Using data from the 'small-ish' smooth of CpA methylation levels on the reverse strand 5. CT-DMRs (forward strand): Using data from the 'small-ish' smooth of CpT methylation levels on the forward strand 6. CT-DMRs (reverse strand): Using data from the 'small-ish' smooth of CpT methylation levels on the reverse strand Previously, we have used BSmooth to perform pairwise (two-group) comparisons 33 . In the present study, we had up to 8 groups to compare: 4 brain regions (BA9, BA24, HC, NAcc) and, for the sorted data, 2 cell types (NeuN + , NeuN -). Rather than running all 28 pairwise comparisons, we extended the BSmooth method to handle multi-group comparisons, which we refer to as the F-statistic method.
For the F-statistic method, we constructed a design matrix with a term for each group (for example, BA9_neg for NeuNcells from BA9, BA9_pos for NeuN + cells from BA9, etc.). For each CpX (CpG, CpA, or CpT), we then fitted a linear model of the smoothed methylation levels against the design matrix. To improve standard error estimates, we thresholded the residual s.d. at the 75% percentile and smoothed these using a running mean over windows containing 101 CpXs. We then combined the estimated coefficients from the linear model, their estimated correlations, and the smoothed residual s.d. to form F-statistics to summarize the evidence that methylation differs between the groups at each of the CpXs.
Next, we identified runs of CpXs where the F-statistic exceeded a cutoff and where each CpX was within a maximum distance of the next. Specifically, we used cutoffs of F = 4.6 2 for CG-DMRs, F = 2 2 for CG-blocks (following 32 ), and F = 4 2 for CA-DMRs and CT-DMRs, and required that the CpXs were within 300 bp of one another for DMRs and 1000 bp of one another for blocks. For blocks, we also required that the average methylation in the block varied by at least 0.1 across the groups. These runs of CpXs formed our candidate DMRs and blocks. Each candidate DMR and block was summarized by the area under the curve formed when treating the F-statistic as a function along the genome (areaStat).
We used permutation testing to assign a measure of statistical significance to each candidate DMR/block. We randomly permuted the design matrix, effectively permuting the sample labels, and repeated the F-statistic analysis with the same cutoffs using the permuted design matrix, resulting in a set of null DMRs/blocks for each permutation. We performed 1000 such permutations. We then asked, for each candidate DMR/block, in how many permutations did we see a null DMR/ block anywhere in the genome with the same or better areaStat as the candidate DMR/block; dividing this number by the total number of permutations gives a permutation P-value for each DMR/block. Since we are comparing each candidate block/DMR against anything found anywhere in the genome in the permutation set, we are also correcting for multiple testing by controlling the family-wise error rate. Those candidates DMRs/blocks with a permutation P-value ≤ 0.05 form our set of DMRs/blocks.
Annotation of small CG-DMRs and CG-blocks.
The F-statistic approach allows us to jointly use all samples for the identification of differentially methylated regions. However, it does not tell us which group(s) are hypomethylated or hypermethylated for the region. To assign such labels to our F-statistic CG-DMRs and CG-blocks, we used a post-hoc analysis for specific pairwise comparisons of interest: NeuN + vs. NeuN -; NeuN + cells in NAcc vs. NeuN + cells in BA9, BA24, and HC; NeuN + cells in NAcc vs. NeuN + cells in BA9. We identified CG-DMRs and CG-blocks using the original t-statistic method of BSmooth; an F-statistic CG-DMR was assigned a label (for example, hypermethylated in NeuN + and hypomethylated in NeuN -) if the corresponding t-statistic CG-DMR or CG-block overlapped at least 50% of the F-statistic CG-DMR or CG-block. This procedure does not change the coordinates of the CG-DMR/CG-block and means an F-statistic CG-DMR/CG-block may be assigned multiple labels. No such analysis was performed for CA-DMRs or CT-DMRs due to computational costs.
Subset analyses of CG-DMRs and CG-blocks.
We found, as expected, that the differences between NeuN + and NeuNsamples dominated our results (98,420 / 100,875 F-statistic CG-DMRs and 19,072 / 20,373 F-statistic CG-blocks were assigned the label, NeuN + vs NeuN -; Supplementary Tables 4, 5 and 6). To better focus on the differences between brain regions within a given cell type (NeuN + or NeuN -), we repeated the F-statistic analysis using just the NeuN + or NeuNsamples ( Supplementary Tables 8, 9, 12 ). We again found that one group dominated: 11,895 / 13,074 F-statistic NeuN + CG-DMRs were specific to NAcc. To better focus on the differences between the remaining brain regions, we repeated the analysis using just the BA9, BA24, and HC NeuN + samples ( Supplementary Table 11 ).
Novel NeuN + vs NeuN -CG-DMRs. Three published data sets of NeuN + vs NeuNmethylation differences 23, 24, 29 were used for comparison with our CG-DMRs. Data from Montano et al. was generated from our own lab and is accessible through GEO series accession number GSE48610. Differentially methylated sites from Kozlenkov et al. 21 were obtained by request directly from the authors. CG-DMRs from Lister et al. 22 were obtained from http://brainome.ucsd.edu/ BrainMethylomeData/CG_DMR_lists.tar.gz and converted to hg19 using the UCSC liftOver tool 55 . As three different platforms were used to measure methylation (CHARM, 450K, and WGBS, respectively), we combined the differentially methylated CpGs from the autosomes of each study and compared to the differentially methylated CpGs within our NeuN + vs NeuN -CG-DMRs. Sites that were unique to our NeuN + vs NeuN -CG-DMRs were reported as novel.
Mapping and quality control of assay for transposase-accessible chromatin using sequencing (ATAC-seq) reads. We trimmed reads of their adaptor sequences using trimadap (v0.1, https://github.com/lh3/trimadap/ archive/0.1.zip) with the following parameters: trimadap-mt − 3 CTGTCTCTTATACACATCTCCGAGCCCACGAGA ${READ1}; trimadap-mt − 3 CTGTCTCTTATACACATCTGACGCTGCCGACGA ${READ2}. We then aligned these trimmed reads to the hg19 build of the human genome (including autosomes, sex chromosomes, mitochondrial sequence, unplaced sequence, and unlocalized sequence) using Bowtie2 56 (v2.2.5) with alignment parameters: bowtie2 -X 2000local-dovetail. Potential PCR duplicate reads were marked using MarkDuplicates from the Picard library (http://broadinstitutfor exampleithub.io/picard/; v2.2.1). Supplementary Table 21 summarizes the alignment results for the 22 libraries.
Identifying differentially accessible ATAC-seq regions (DARs) . Peaks were called in each condition (NAcc_pos, NAcc_neg, BA9_pos, and BA9_neg) using MACS 57 (v2.1.0). Specifically, data from each condition were combined into a metasample formed by using all non-duplicate-marked reads with a mapping quality > 30 and then processed using: macs2 callpeaks-nomodel-nolambda-call-summits -t ${BAMS[@]}. We took the 'narrowPeaks' produced by MACS and filtered out those regions overlapping the ENCODE mappability consensus blacklist regions (http:// hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/) and the blacklist for ATAC-seq created by Buenrostro et al 38 . (https://sites.google.com/ site/atacseqpublic/atac-seq-analysis-methods/mitochondrialblacklists-1). We took this filtered list as our condition-specific sets of open chromatin regions (OCRs).
To perform the differential analysis, we first took the union of conditionspecific OCRs on the autosomes to construct an 'overall' set of OCRs. This 'overall' set of OCRs contained 853,053 regions (630 Mb). For each sample, we then counted the number of fragments (fragment = start of read1 to end of read2) overlapping each of the 'overall' OCRs using the summarizeOverlaps() function in the GenomicAlignments R/Bioconductor package 58 (v1.10.0). Specifically, we only counted those fragments where both reads had a mapping-quality score > 30, reads not marked as potential PCR duplicates, and those where any part of the fragment overlapped exactly one peak.
We then analyzed these data using the voom method, originally designed for differential expression analysis of RNA-seq data 59 . Briefly, the read counts were transformed to counts per million (cpm) and only those 283,812 / 853,053 peaks with at least 1 cpm for at least 5 samples (the size of the smallest group of samples) were retained. These 283,812 peaks were used in all downstream analyses of differential accessibility described in the main text. We normalized these counts using TMM 60 , then used edgeR 61 (v3.16.5) and limma 62 (v3.30.7) to transform these counts to log 2 -cpm, estimate the mean-variance relationship, and compute appropriate observation-level weights ready for linear modelling.
In our design matrix, we blocked on donor (donor1, … , donor6) and included a term for each group (for example, BA9_neg for NeuNcells from BA9, BA9_pos for NeuN + cells from BA9, etc.). We ran surrogate variable analysis 63 using the sva (v3.22.0) R/Bioconductor package and identified 4 surrogate variables. We ultimately decided to include all 4 surrogate variables in the linear model. Using the empirical Bayes shrinkage method implemented in limma, we tested for differential accessibility of peaks in three comparisons: (1) NAcc vs. BA9 in NeuN + cells; (2) NAcc vs. BA9 in NeuNcells; (3) NeuN + cells vs NeuNcells. For an ATAC-seq peak to be called a differentially accessible region (DAR), it had to have a Benjamini-Hochberg adjusted P-value < 0.05.
Mapping and quality control of RNA-seq reads. We trimmed the first 3 bp of read1, which were derived from template switching oligos and not the cDNA of interest, using seqtk (https://github.com/lh3/seqtk; v1.2-r94) with the following parameters: seqtk trimfq -b 3 ${READ1}. We then quasi-mapped these trimmed reads to a FASTA file of protein-coding and lncRNA genes from GENCODE v19 (https:// www.gencodegenes.org/human/release_19.html) 51 and performed transcript-level quantification using Salmon 64 (v0.7.2) . Supplementary Table 16 summarizes these results for the 20 libraries.
Identifying differentially expressed genes (DEGs). We used tximport 65 (v1.2.0) to compute normalized gene-level counts from the transcript-level abundance estimates (scaling these using the average transcript length over samples and the library size) for autosomal genes (33,351 genes) . Only autosomal genes with at least 1 cpm in at least 4 libraries (the size of the smallest group of samples) were retained for downstream analysis (24,161 / 33,351 genes) . We normalized these counts using TMM 60 then used edgeR 61 (v3.16.5) and limma 62 (v3.30.7) to transform these counts to log 2 -cpm, estimate the mean-variance relationship, and compute appropriate observation-level weights ready for linear modelling.
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In our design matrix, we blocked on donor (donor1, … , donor6) and included a term for each group (for example, BA9_neg for NeuNcells from BA9, BA9_pos for NeuN + cells from BA9, etc.). We ran surrogate variable analysis 63 using the sva (v3.22.0) R/Bioconductor package and identified 5 surrogate variables, some of which correlated with the date on which these samples were flow-sorted. We ultimately decided to include all 5 surrogate variables in the linear model. Using the empirical Bayes shrinkage method implemented in limma, we tested for differential expression of genes in three comparisons: (1) NAcc vs. BA9 in NeuN + cells; (2) NAcc vs. BA9 in NeuNcells; (3) NeuN + cells vs NeuNcells. For a gene to be called a differentially expressed gene (DEG), it had to have a Benjamini-Hochberg adjusted P-value < 0.05 with no minimum log 2 fold change cutoff.
Enrichment odds ratios and P-values. We formed a 2 × 2 contingency table of (n 11 , n 12 , n 21 , n 22 ); specific values of (n 11 , n 12 , n 21 , n 22 ) are described below. The enrichment log odds ratio was estimated by log 2 (OR) = log 2 (n 11 ) + log 2 (n 22 )log 2 (n 12 ) -log 2 (n 21 ), its standard error was estimated by se(log 2 (OR)) = sqrt(1 / n 11 + 1 / n 12 + 1 / n 21 + 1 / n 22 ) , and an approximate 95% confidence interval formed by [log 2 (OR) -2 × se(log 2 (OR)), log 2 (OR) + 2 × se(log 2 (OR))]. We also report the P-value obtained from performing Fisher's exact test for testing the null of independence of rows and columns in the 2 × 2 table (that is the null of no enrichment or depletion) using the fisher.test() function from the 'stats' package in R 66 .
Enrichment of DMRs and blocks in genomic features.
For DMRs and blocks, we computed the enrichment of CpXs (CpGs, CpAs, or CpTs, as appropriate) within DMRs inside each genomic feature (for example, exons, FANTOM5 enhancers, etc.). Specifically, for each genomic feature, we constructed the 2 × 2 table (n11, n12, n21, n22), where:
• n 11 = Number of CpXs in DMRs/blocks that were inside the feature • n 12 = Number of CpXs in DMRs/blocks that were outside the feature • n 21 = Number of CpXs not in DMRs/blocks that were inside the feature • n 22 = Number of CpXs not in DMRs/blocks that were outside the feature The total number of CpXs, n = n 11 + n 12 + n 21 + n 22 , was the number of autosomal CpXs in the reference genome. We counted CpXs rather than the number of DMRs or bases because this accounts for the non-uniform distribution of CpXs along the genome and avoids double-counting DMRs that are both inside and outside the feature.
Enrichment of open chromatin regions (OCRs) in genomic features.
For OCRs, we computed the enrichment of bases within OCRs inside each genomic feature. Specifically, for each genomic feature, we constructed the 2 × 2 table (n11, n12, n21, n22), where:
• n 11 = Number of bases in OCRs that were inside the feature • n 12 = Number of bases in OCRs that were outside the feature • n 21 = Number of bases in the rest of the genome that were inside the feature • n 22 = Number of bases in the rest of the genome that were outside the feature The total number of bases, n = n 11 + n 12 + n 21 + n 22 , was the number of autosomal bases in the reference genome. We counted bases rather than number of OCRs to account for the variation in OCR width, the large variation in width for the 'rest of the genome' features, and to avoid double-counting OCRs that were both inside and outside the feature.
Enrichment of differentially accessible regions (DARs) in genomic features. For DARs,
we computed the enrichment of bases within DARs inside each genomic feature in two ways. First, for each genomic feature, we constructed the 2 × 2 table (n11, n12, n21, n22), where:
• n 11 = Number of bases in DARs that were inside the feature • n 12 = Number of bases in DARs that were outside the feature • n 21 = Number of bases in the rest of the genome that were inside the feature • n 22 = Number of bases in the rest of the genome that were outside the feature Second, for each genomic feature, we constructed the 2 × 2 table (n11, n12, n21, n22), where:
• n 11 = Number of bases in DARs that were inside the feature • n 12 = Number of bases in DARs that were outside the feature • n 21 = Number of bases in null-regions that were inside the feature • n 22 = Number of bases in null-regions that were outside the feature 'Null-regions' were those OCRs that were not differentially accessible between the relevant condition (NAcc and BA9 in NeuN + cells) based on the peak having a Benjamini-Hochberg adjusted P value > 0.05 in the analysis of differential accessibility. By comparing to null-regions rather than the rest of the genome, we account for the non-uniform distribution of OCRs along the genome.
We counted the number of bases rather than the number of DARs to account for the variation in DAR width and to avoid double-counting DARs that were both inside and outside the feature.
Association of gene body methylation and chromatin accessibility with gene expression. We analyzed the relationship between gene body methylation and chromatin accessibility with gene expression using protein coding genes (n = 19,823). We focused on data from NAcc (NeuN + ) and BA9 (NeuN + ) samples because for these brain regions we had WGBS, ATAC-seq, and RNA-seq, as well as a substantial number of 'DiffEpi' marks ('DiffEpi' being a collective abbreviation for DMRs, blocks, and DARs).
To examine the spatial distribution of DiffEpi marks around gene bodies, we took 100 bins across each gene and recorded whether that bin overlapped a DiffEpi mark. We extended this for 2 gene body equivalents upstream of the transcription start site (TSS) and downstream of the transcription end site (TES) (that is if a gene was 1 kb long then we extended it 2 kb upstream of TSS and 2 kb downstream of TES) and similarly recorded whether each bin overlapped a DiffEpi mark. Fig. 4a plots the proportion of genes with a DiffEpi mark in each bin as we move from upstream of the TSS, across the gene body, and downstream of the TES, stratified by whether the gene was differentially expressed between NAcc (NeuN + ) and BA9 (NeuN + ) samples.
We performed various analyses of the relationship between mCA (taking estimates from the same strand as the gene), mCG (aggregated over strand and so 'unstranded'), and average chromatin accessibility (ATAC-seq reads-per-kilobase mapped (RPKM)) with gene expression (RNA-seq RPKM) for all protein coding genes for NAcc (NeuN + ) and BA9 (NeuN + ) samples. We examined these features over gene bodies and gene promoters, as well as in bins along and surrounding each gene. Different types of bins were used for different analyses, as noted in figure captions. For some analyses we used a fixed number of bins for each gene so that bin width varied according to gene width (for example, 100 bins covering the gene body in Fig. 4a and Supplementary Fig. 8a ). For other analyses, we used a fixed bin size (for example, 1 kb bins upstream of TSS and downstream of TES in Fig. 4b ). Furthermore, some analyses used scaled distances upstream of the TSS and downstream of the TES (for example, Fig. 4a and Supplementary Fig. 8a ) while others used fixed distances (for example, Fig. 4b ).
We then focused on correlating DiffEpi marks with changes in gene expression. We again took all protein coding genes and created 100 bins across each gene body. We identified all DiffEpi marks that overlapped each bin and correlated the change in methylation (mCG from small smooth for CG-DMRs; mCG from large smooth for CG-blocks; mCA on the same strand as the gene for CA-DMRs) or change in chromatin accessibility (log 2 FC using RPKM for DARs) with the change in expression of the gene (log 2 FC). To emphasize, only genes with a DiffEpi mark in that bin contribute to the correlation estimate for that bin. We performed a similar procedure upstream of the TSS and downstream of the TES, but here using a fixed bin size (1 kb).
Finally, we used a binomial generalized additive model to estimate the probability that a protein coding gene is differentially expressed given that x% of the gene body is covered by a DiffEpi mark. The 'gam' function in the 'mgcv' package 67 (v1.8-23) was used to fit the generalized additive model with the formula y ~bs(x, bs = "cs") and additional argument family = "binomial". This estimated probability and its standard error are shown in Fig. 4c , annotated with example genes.
Stratified linkage disequilibrium score regression (SLDSR). We used SLDSR, implemented in the LDSC 68 software, to evaluate the enrichment of common genetic variants from GWAS signals to partition trait heritability within functional categories represented by our DMRs, OCRs, and DARs 51 . SLDSR estimates the proportion of genome-wide single nucleotide polymorphism (SNP)-based heritability that can be attributed to SNPs within a given genomic feature by a regression model that combines GWAS summary statistics with estimates of linkage disequilibrium from an ancestry-matched reference panel. Links to GWAS summary statistics are available in Supplementary Table 24 . Additional files needed for the SLDSR analysis were downloaded from https://data.broadinstitute.org/alkesgroup/LDSCORE/ following instructions at https://github.com/bulik/ldsc/wiki. We ran LDSC (v1.0.0; https://github.com/bulik/ldsc) to estimate the proportion of genome-wide SNP-based heritability of 30 traits ( Supplementary Table 24 ) across 53 'baseline' genomic features (24 main annotations, 500 bp windows around of each of the 24 main annotations, and 100 bp windows around 5 sets of ChIP-seq peaks; described in ref. 51 ) and eight brain-specific genomic features:
ResouRce Nature NeuroscieNce HMM using Roadmap Epigenomics 15 data (498.1 Mb). The selected brain regions and their Roadmap Epigenomics codes were: Brain Angular Gyrus (E067); Brain Anterior Caudate (E068); Brain Cingulate Gyrus (E069); Brain Germinal Matrix (E070); Brain Hippocampus Middle (E071); Brain Inferior Temporal Lobe (E072); Brain Dorsolateral Prefrontal Cortex (E073); Brain Substantia Nigra (E074); Fetal Brain Male (E081); Fetal Brain Female (E082). The ChromHMM states selected as 'regulatory regions' were: Bivalent Enhancer; Bivalent/Poised TSS; Genic enhancers; Flanking Active TSS; Active TSS; Strong transcription; Enhancers. Processed ChromHMM tracks were downloaded using the AnnotationHub R/Bioconductor package (v1.36.2).
Collectively, we refer to features 1-5 as 'differential features' , being the product of differential analyses, and features 6-8 as 'non-differential features' , each being the union of regions marked by various active histone modifications present in different brain regions.
We performed three rounds of analysis:
1. 'Baseline': A standard SLDSR analysis, as suggested by the LDSC authors, whereby each of the eight brain-specific features was added one at a time to a 'full baseline model' that included the 53 'baseline' categories that capture a broad set of genomic annotations. 2. 'Stringent': Add each of the 5 differential features one at a time to a model that included the 53 baseline features and 3 brain-specific non-differential features. 3. ' Adjusting for non-differential features (ndf) excluding differential features (df)': Add each of the 5 differential features on at a time to a model that included the 3 brain-specific non-differential features (after having excluded any regions shared with the brain-specific differential feature) and the 53 baseline features.
For each round of analysis, we used SLDSR to estimate a 'coefficient z-score' and an 'enrichment score' for each feature-trait combination. A brief description of their interpretation is given below; we refer the interested reader to the Online Methods of Finucane, H.K. et al. 27 for the complete mathematical derivation.
A coefficient z-score statistically larger than zero indicates that adding the feature to the model increased the explained heritability of the trait, beyond the heritability explained by other features in the model.
The enrichment score is defined as (proportion of heritability explained by the feature) / (proportion of SNPs in the feature). The enrichment score is unadjusted for the other features in the model, but is more readily interpretable as an effect size. It should be noted, however, that the enrichment score depends on the terms included in the model. Although the denominator of the enrichment score is constant, the numerator depends on the set of features in the model and how much the feature of interest overlaps the other features in the set. In particular, the "proportion of heritability explained by the feature" will decrease when another feature that overlaps it is added to the model (for example, the enrichment scores of the differential features in the 'stringent' analysis are lower than in the 'baseline' analysis due to the differential features overlapping the non-differential features that are added to the baseline in the 'stringent' analysis).
Particularly interesting are those feature-trait combinations with statistically significant z-score coefficients and large enrichment scores. P-values within each trait were post-hoc adjusted for multiple testing using Holm's method 69 ( Supplementary Table 25 ).
Transcription factor motif enrichment. We used the Haystack (v0.4) 40 haystack_motifs module to scan for vertebrate JASPAR (2016) 70 transcription factor binding motifs enriched in our data sets. A list of neuronal DARs that overlapped hypo-or hypermethylated neuronal CG-DMRs identified between NAcc and BA9 in NeuN + nuclei were input into Haystack as a BED file (hyper CG-DMR/ DARs, n = 14,463; hypo CG-DMR/DARs, n = 11,734). A subset of these neuronal DAR-CG-DMRs found in promoters was analyzed separately (hyper CG-DMR/ DARs, n = 2,618; hypo CG-DMR/DARs, n = 1,435). All autosomal promoters were input as background for the neuronal DAR-CG-DMRs that overlapped promoters. For the complete list of neuronal DAR-CG-DMRs, Haystack selected a random, CG-content-matched subset of the input background to use for enrichment calculations. Significance was determined using a one-sided Fisher's test.
To identify novel transcriptional regulators for the differentially expressed genes found between NeuN + populations from NAcc and BA9, we first generated transcription factor gene scores using TEPIC 49 . This software utilizes epigenetic information along with transcription factor binding sites to generate these scores, which can then be used by DYNAMITE 48 to infer potentially important transcriptional regulators by predicting up-or downregulation for differentially expressed genes. Using the combined TEPIC/DYNAMITE pipeline, transcription factor affinities were computed within the DARs identified between NeuN + nuclei from NAcc and BA9 (n = 68,021) using the provided human_jaspar_hoc_kellis. PSEM position weight matrix. The affinities per gene were calculated over a 5 kb window around a gene's TSS, incorporating the signal abundance (cpm) within a peak into the transcription factor annotation. We also provided the log 2 gene expression ratios for DEGs between NeuN + nuclei from NAcc and BA9 (n = 2,952). Other input parameters used: outerCV = 6, innerCV = 10, alpha_Step_Size = 0.01. We reported only those transcription factors that were expressed in our NeuN + nuclei and had a correlation coefficient > |0.04| in Fig. 4f . The full output (including transcription factors not expressed in our samples) is reported in Supplementary Table 23 .
